ArticleTranslational lung cancer research2022

Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial.

Quan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.